|
⚲
|
| Keyboard |
| Maha Katabi | |
|---|---|
| Firm | |
| Address | c/o Star Therapeutics LLC 201 Haskins Way, 5th Floor South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Star Therapeutics LLC | 021-559890 | Director | 125.0 M of 125.0 M |
||
| Marea Therapeutics Inc | 021-516752 | Director | 65.4 M of 160.4 M |
||
| Quanta Therapeutics Inc | 021-482575 | Director | 50.7 M of 55.0 M |
||
| Quanta Therapeutics Inc | 021-473779 | Director | 30.0 M of 30.0 M |
||
| Rayzebio Inc | 021-459654 | Director | 167.9 M of 167.9 M |
||
| Quanta Therapeutics Inc | 021-419719 | Director | 40.2 M of 70.2 M |
||
| Gyroscope Therapeutics Ltd | 021-395903 | Director | 148.0 M of 148.0 M |
||
| Vera Therapeutics Inc | 021-390559 | Director | 70.7 M of 70.7 M |
||
| Aerovate Therapeutics Inc | 021-373292 | Director | 75.8 M of 75.8 M |
||
| Apellis Pharmaceuticals Inc | 021-293019 | Director | 20.0 M of 60.1 M |
||
| Effector Therapeutics Inc | 021-253725 | Director | 56.0 M of 56.0 M |
||
| Sofinnova Investments Inc | |||||
| Sofinnova Venture Partners XII LP | 021-532792 | Executive Officer | 500.0 M of 550.0 M |
20.5 M | |
| Sofinnova Venture Partners Xi LP | 021-412971 | Executive Officer | 500.0 M of 500.0 M |
308.7 M | |